0238-DST-High Content Screening System with Confocal and Widefield Modalities
Estimated value
£750k
Awarded value
—
Suppliers
0
Lots
1
Published
31 Oct 2022
Description
The Advanced Technologies team at the Medicines Discovery Catapult (MDC) is looking to expand its current advanced microscopy facility to support both our own growing needs and provide the UK SME community access to advanced molecular and cellular imaging. MDC is aiming purchase a confocal High Content Screening (HCS) instrument based on an automated well-plate inverted microscope, together with confocal and widefield functionalities. It is crucial for the HCS system to be flexible and provide fast and high-resolution imaging of a wide range of experiments. The instrument should be configured to enable the use of different sample formats (2D and 3D cell models, tissue sections, fixed and live-cell) and experimental types (drug dose responses, live-cell kinetic studies, phenotypic screening, RNA scope), using a large variety of well-plate formats and a wide range of fluorophores. In addition, the HCS instrument must be supplied with a high-end solution for high content image analysis, visualization and handling. For more information, please follow this link - https://procontract.due-north.com/Advert?advertId=3e1c3152-f658-ed11-811b-9f38301b3091
Scope
- Reference
- MEDDISC001-DN640362-94376882
- Total value
- £750,000 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 03 Jan 2023 to 02 Jan 2027
- CPV classifications
- 38000000
Submission & procedure
- Submission deadline
- 21 Nov 2022, 12:00 pm